Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Inflammatory bowel disease is a condition generally caused when immune system attacks harmless bacteria, virus, or food in the intestine. The most common inflammatory bowel diseases are ulcerative colitis and Crohns disease.
The growth in prevalence of inflammatory bowel diseases such as ulcerative colitis and Crohn's disease majorly drives the growth of the market. In addition, increase in intake of unhealthy food and drinks, and sedentary and stressful lifestyle propels the growth of the market. The increase in healthcare expenditure by government and private organizations is anticipated to increase the market growth.
The report details the trend, potential and market size of Inflammatory Bowel Disease Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Inflammatory Bowel Disease Drugsmarket, defines the market attractiveness level of Inflammatory Bowel Disease Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Inflammatory Bowel Disease Drugs industry, describes the types of Inflammatory Bowel Disease Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Inflammatory Bowel Disease Drugs market and the development prospects and opportunities of Inflammatory Bowel Disease Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Inflammatory Bowel Disease Drugs market in Chapter 13.
By Player:
Novartis AG
Mylan Pharmaceuticals
Abbott Laboratories
Sanofi
Pfizer
Roche
Takeda Pharmaceutical
Quest Medical
Biocon Ltd
Johnson and Johnson
By Type:
Ulcerative Colitis
Crohns Disease
Indeterminate Colitis
Others
By End-User:
Amino-salicylates
Antibiotics
Corticosteroids
Immunomodulators
Biologics
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Inflammatory Bowel Disease Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Inflammatory Bowel Disease Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Inflammatory Bowel Disease Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Inflammatory Bowel Disease Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Inflammatory Bowel Disease Drugs Market Analysis and Outlook to 2022
-
7.1 Global Inflammatory Bowel Disease Drugs Consumption (2017-2022)
-
7.2 United States Inflammatory Bowel Disease Drugs Consumption (2017-2022)
-
7.3 Europe Inflammatory Bowel Disease Drugs Consumption (2017-2022)
-
7.4 China Inflammatory Bowel Disease Drugs Consumption (2017-2022)
-
7.5 Japan Inflammatory Bowel Disease Drugs Consumption (2017-2022)
-
7.6 India Inflammatory Bowel Disease Drugs Consumption (2017-2022)
-
7.7 South Korea Inflammatory Bowel Disease Drugs Consumption (2017-2022)
8 Region and Country-wise Inflammatory Bowel Disease Drugs Market Analysis and Outlook to 2028
-
8.1 Global Inflammatory Bowel Disease Drugs Consumption Forecast (2022-2028)
-
8.2 United States Inflammatory Bowel Disease Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Inflammatory Bowel Disease Drugs Consumption Forecast (2022-2028)
-
8.4 China Inflammatory Bowel Disease Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Inflammatory Bowel Disease Drugs Consumption Forecast (2022-2028)
-
8.6 India Inflammatory Bowel Disease Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Inflammatory Bowel Disease Drugs Consumption Forecast (2022-2028)
9 Global Inflammatory Bowel Disease Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Inflammatory Bowel Disease Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Ulcerative Colitis Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Crohns Disease Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Indeterminate Colitis Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Inflammatory Bowel Disease Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Amino-salicylates Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Antibiotics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Corticosteroids Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Immunomodulators Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Biologics Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Others Consumption and Growth Rate (2017-2022)
10 Global Inflammatory Bowel Disease Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Inflammatory Bowel Disease Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Ulcerative Colitis Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Crohns Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Indeterminate Colitis Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Inflammatory Bowel Disease Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Amino-salicylates Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Antibiotics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Immunomodulators Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Biologics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Inflammatory Bowel Disease Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Inflammatory Bowel Disease Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Inflammatory Bowel Disease Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Inflammatory Bowel Disease Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Inflammatory Bowel Disease Drugs Market Competitive Analysis
-
14.1 Novartis AG
-
14.1.1 Novartis AG Company Details
-
14.1.2 Novartis AG Inflammatory Bowel Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis AG Inflammatory Bowel Disease Drugs Product and Service
-
14.2 Mylan Pharmaceuticals
-
14.2.1 Mylan Pharmaceuticals Company Details
-
14.2.2 Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Product and Service
-
14.3 Abbott Laboratories
-
14.3.1 Abbott Laboratories Company Details
-
14.3.2 Abbott Laboratories Inflammatory Bowel Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Abbott Laboratories Inflammatory Bowel Disease Drugs Product and Service
-
14.4 Sanofi
-
14.4.1 Sanofi Company Details
-
14.4.2 Sanofi Inflammatory Bowel Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Sanofi Inflammatory Bowel Disease Drugs Product and Service
-
14.5 Pfizer
-
14.5.1 Pfizer Company Details
-
14.5.2 Pfizer Inflammatory Bowel Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pfizer Inflammatory Bowel Disease Drugs Product and Service
-
14.6 Roche
-
14.6.1 Roche Company Details
-
14.6.2 Roche Inflammatory Bowel Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Roche Inflammatory Bowel Disease Drugs Product and Service
-
14.7 Takeda Pharmaceutical
-
14.7.1 Takeda Pharmaceutical Company Details
-
14.7.2 Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Product and Service
-
14.8 Quest Medical
-
14.8.1 Quest Medical Company Details
-
14.8.2 Quest Medical Inflammatory Bowel Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Quest Medical Inflammatory Bowel Disease Drugs Product and Service
-
14.9 Biocon Ltd
-
14.9.1 Biocon Ltd Company Details
-
14.9.2 Biocon Ltd Inflammatory Bowel Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Biocon Ltd Inflammatory Bowel Disease Drugs Product and Service
-
14.10 Johnson and Johnson
-
14.10.1 Johnson and Johnson Company Details
-
14.10.2 Johnson and Johnson Inflammatory Bowel Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Johnson and Johnson Inflammatory Bowel Disease Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Inflammatory Bowel Disease Drugs
-
Figure Inflammatory Bowel Disease Drugs Picture
-
Table Global Inflammatory Bowel Disease Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Inflammatory Bowel Disease Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Inflammatory Bowel Disease Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Inflammatory Bowel Disease Drugs Consumption by Country (2017-2022)
-
Figure United States Inflammatory Bowel Disease Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Inflammatory Bowel Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Inflammatory Bowel Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Inflammatory Bowel Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Inflammatory Bowel Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Inflammatory Bowel Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Inflammatory Bowel Disease Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Inflammatory Bowel Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Inflammatory Bowel Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Inflammatory Bowel Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Inflammatory Bowel Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Inflammatory Bowel Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Inflammatory Bowel Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ulcerative Colitis Consumption and Growth Rate (2017-2022)
-
Figure Global Crohns Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Indeterminate Colitis Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Amino-salicylates Consumption and Growth Rate (2017-2022)
-
Figure Global Antibiotics Consumption and Growth Rate (2017-2022)
-
Figure Global Corticosteroids Consumption and Growth Rate (2017-2022)
-
Figure Global Immunomodulators Consumption and Growth Rate (2017-2022)
-
Figure Global Biologics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Ulcerative Colitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Crohns Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Indeterminate Colitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Amino-salicylates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antibiotics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunomodulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biologics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Inflammatory Bowel Disease Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Inflammatory Bowel Disease Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Inflammatory Bowel Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Inflammatory Bowel Disease Drugs Product and Service
-
Table Mylan Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Inflammatory Bowel Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Inflammatory Bowel Disease Drugs Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Inflammatory Bowel Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Inflammatory Bowel Disease Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inflammatory Bowel Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inflammatory Bowel Disease Drugs Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Inflammatory Bowel Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Inflammatory Bowel Disease Drugs Product and Service
-
Table Takeda Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Product and Service
-
Table Quest Medical (Foundation Year, Company Profile and etc.)
-
Table Quest Medical Inflammatory Bowel Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Quest Medical Inflammatory Bowel Disease Drugs Product and Service
-
Table Biocon Ltd (Foundation Year, Company Profile and etc.)
-
Table Biocon Ltd Inflammatory Bowel Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Ltd Inflammatory Bowel Disease Drugs Product and Service
-
Table Johnson and Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson and Johnson Inflammatory Bowel Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson and Johnson Inflammatory Bowel Disease Drugs Product and Service
-
